pharma_company
stringclasses 562
values | brand_name_en
stringlengths 19
232
| generic_name_en
stringlengths 21
250
| substance_name_en
stringclasses 983
values | atc_code_raw
stringclasses 778
values | anatomical_desc
stringclasses 14
values | therapeutic_desc
stringclasses 82
values | pharmacological_desc
stringclasses 181
values | subpharmacological_desc
stringclasses 365
values | chemical_desc
stringclasses 636
values |
---|---|---|---|---|---|---|---|---|---|
Amin Pharmaceutical Co.
|
SERAMIN TABLET ORAL 100 mg
|
QUETIAPINE FUMARATE TABLET ORAL 100 mg
|
QUETIAPINE FUMARATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Zagros Darou Parsian
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS ORAL 20 mg
|
OMEPRAZOLE
|
A02BC01
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
omeprazole
|
Sobhandarou
|
SERMENTA TABLET ORAL 50 mg
|
SERTRALINE (AS HYDROCHLORIDE) TABLET ORAL 50 mg
|
SERTRALINE (AS HYDROCHLORIDE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Razak Labratories
|
CIPROFLOXACIN TABLET ORAL 500 mg
|
CIPROFLOXACIN TABLET ORAL 500 mg
|
CIPROFLOXACIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Daru
|
PREGABALIN CAPSULE ORAL 75 mg
|
PREGABALIN CAPSULE ORAL 75 mg
|
PREGABALIN
|
N03AX16
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Other antiepileptics
|
pregabalin
|
Aryapharmaceutical
|
TOPIRAMATE ARYA TABLET ORAL 25 mg
|
TOPIRAMATE TABLET ORAL 25 mg
|
TOPIRAMATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
VALSARTAN-HAKIM TABLET ORAL 160 mg
|
VALSARTAN TABLET ORAL 160 mg
|
VALSARTAN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Kedrion
|
TETANUS GAMMA INJECTION PARENTERAL 250 [iU]/1mL [iU]
|
TETANUS IMMUNE GLOBULIN INJECTION PARENTERAL 250 [iU]/1mL
|
TETANUS IMMUNE GLOBULIN
|
J06BB02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
IMMUNE SERA AND IMMUNOGLOBULINS
|
IMMUNOGLOBULINS
|
Specific immunoglobulins
|
tetanus immunoglobulin
|
Exir Pharmaceutical Company
|
ZIMEXIR POWDER, FOR SUSPENSION ORAL 200 mg/5mL 30 mL
|
AZITHROMYCIN POWDER, FOR SUSPENSION ORAL 200 mg/5mL 30 mL
|
AZITHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
BIPERIDEN TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE
|
N04AA02
|
NERVOUS SYSTEM
|
ANTI-PARKINSON DRUGS
|
ANTICHOLINERGIC AGENTS
|
Tertiary amines
|
biperiden
|
Mina Pharmaceutical&cosmetics Laboratory
|
DIPHENHYDRAMINE COMPOUND SYRUP ORAL 12.5 mg/125 mg/5mL 60 mL
|
DIPHENHYDRAMINE / AMMONIUM CHLORIDE SYRUP ORAL 12.5 mg/125 mg/5mL 60 mL
|
DIPHENHYDRAMINE / AMMONIUM CHLORIDE
|
R06AA52
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Aminoalkyl ethers
|
diphenhydramine, combinations
|
Exir Pharmaceutical Company
|
TETRACOSACTIDE LA INJECTION, SUSPENSION PARENTERAL 1 mg/1mL mL
|
TETRACOSACTIDE ACETATE INJECTION, SUSPENSION PARENTERAL 1 mg/1mL
|
TETRACOSACTIDE ACETATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pars Darou
|
KETOTIFEN TABLET ORAL 1 mg
|
KETOTIFEN TABLET ORAL 1 mg
|
KETOTIFEN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Alborzdarou
|
NITROCARDIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN
|
C01DA02
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
VASODILATORS USED IN CARDIAC DISEASES
|
Organic nitrates
|
glyceryl trinitrate
|
Sydler
|
SYDFLU CAPSULE ORAL 75 mg
|
OSELTAMIVIR (AS PHOSPHATE) CAPSULE ORAL 75 mg
|
OSELTAMIVIR (AS PHOSPHATE)
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Pharmachemie
|
ASA TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID) TABLET, DELAYED RELEASE ORAL 80 mg
|
ASA (ACETYLSALICYLIC ACID)
|
B01AC06
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTITHROMBOTIC AGENTS
|
ANTITHROMBOTIC AGENTS
|
Platelet aggregation inhibitors excl. heparin
|
acetylsalicylic acid
|
Exir Pharmaceutical Company
|
KLAREXIR POWDER, FOR SUSPENSION ORAL 125 mg/5 mL 100 mL
|
CLARITHROMYCIN POWDER, FOR SUSPENSION ORAL 125 mg/5 mL 100 mL
|
CLARITHROMYCIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Chemidarou
|
TIAGRIX TABLET ORAL 10 mg
|
TADALAFIL TABLET ORAL 10 mg
|
TADALAFIL
|
G04BE08
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
UROLOGICALS
|
UROLOGICALS
|
Drugs used in erectile dysfunction
|
tadalafil
|
Fanavarihaye Novin Darouie Atieh
|
DEPRILAX CAPSULE, EXTENDED RELEASE ORAL 37.5 mg
|
VENLAFAXINE CAPSULE, EXTENDED RELEASE ORAL 37.5 mg
|
VENLAFAXINE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhan Oncology
|
PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 50 mL
|
PACLITAXEL INJECTION PARENTERAL 6 mg/1mL 50 mL
|
PACLITAXEL
|
L01CD01
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ANTINEOPLASTIC AGENTS
|
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
|
Taxanes
|
paclitaxel
|
Daana Pharma
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 g
|
CEFALEXIN POWDER, FOR SUSPENSION ORAL 125 mg/5mL 100 mL
|
CEFALEXIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Darou Pakhsh
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL mL
|
VITAMIN B12 INJECTION PARENTERAL 1000 ug/1mL
|
VITAMIN B12
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Daana Pharma
|
NITROGLYCERIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN TABLET, EXTENDED RELEASE ORAL 6.4 mg
|
NITROGLYCERIN
|
C01DA02
|
CARDIOVASCULAR SYSTEM
|
CARDIAC THERAPY
|
VASODILATORS USED IN CARDIAC DISEASES
|
Organic nitrates
|
glyceryl trinitrate
|
Alborzdarou
|
PEDICOLD SYRUP ORAL 0.67 mg/10 mg/5mL 60 mL
|
PEDIATRIC GRIPPE SYRUP ORAL 0.67 mg/10 mg/5mL 60 mL
|
PEDIATRIC GRIPPE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Fatak Chemie Pars Pharmaceutical Co.
|
METHOCARBAMOL TABLET ORAL 500 mg
|
METHOCARBAMOL TABLET ORAL 500 mg
|
METHOCARBAMOL
|
M03BA03
|
MUSCULO-SKELETAL SYSTEM
|
MUSCLE RELAXANTS
|
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
|
Carbamic acid esters
|
methocarbamol
|
Jalinous Pharmaceutical Co.
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN TABLET ORAL 500 mg
|
LEVOFLOXACIN
|
J01MA12
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Fluoroquinolones
|
levofloxacin
|
Actero middleeast
|
TEMOZOLOMIDE ACTE CAPSULE ORAL 250 mg
|
TEMOZOLOMIDE CAPSULE ORAL 250 mg
|
TEMOZOLOMIDE
|
L01AX03
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ANTINEOPLASTIC AGENTS
|
ALKYLATING AGENTS
|
Other alkylating agents
|
temozolomide
|
Noavaran Daroui Kimia
|
IMATINIB CAPSULE ORAL 100 mg
|
IMATINIB (AS MESYLATE) CAPSULE ORAL 100 mg
|
IMATINIB (AS MESYLATE)
|
L01XE01
|
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
|
ANTINEOPLASTIC AGENTS
|
OTHER ANTINEOPLASTIC AGENTS
| null | null |
Kishmedipharm
|
AMYOGER TABLET ORAL 50 mg
|
RILUZOLE TABLET ORAL 50 mg
|
RILUZOLE
|
N07XX02
|
NERVOUS SYSTEM
|
OTHER NERVOUS SYSTEM DRUGS
|
OTHER NERVOUS SYSTEM DRUGS
|
Other nervous system drugs
|
riluzole
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
DOMPERIDONE-SHAFA TABLET ORAL 10 mg
|
DOMPERIDONE TABLET ORAL 10 mg
|
DOMPERIDONE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Hakim Pharmaceutical Co.
|
PROPRANOLOL-HAKIM TABLET ORAL 40 mg
|
PROPRANOLOL HYDROCHLORIDE TABLET ORAL 40 mg
|
PROPRANOLOL HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Avicenna Laboratories Inc.
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR TABLET ORAL 200 mg
|
ACICLOVIR
|
J05AB01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
aciclovir
|
null |
TOLTERODINE (TASNIM) 2MG EXTENDED RELEASE CAP CAPSULE, EXTENDED RELEASE ORAL 2 mg
|
TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE ORAL 2 mg
|
TOLTERODINE TARTRATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Unither Pharma
|
EPILIM SYRUP ORAL 200 mg/5mL 300 g
|
VALPROATE SODIUM SYRUP ORAL 200 mg/5mL 300 mL
|
VALPROATE SODIUM
|
N03AG01
|
NERVOUS SYSTEM
|
ANTIEPILEPTICS
|
ANTIEPILEPTICS
|
Fatty acid derivatives
|
valproic acid
|
Emad Darman Pars
|
CLOBETASOL-EMAD OINTMENT TOPICAL 0.05 % 15 g
|
CLOBETASOL PROPIONATE OINTMENT TOPICAL 0.05 % 15 g
|
CLOBETASOL PROPIONATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
FUSITAN OINTMENT TOPICAL 2 % 15 g
|
FUSIDATE SODIUM OINTMENT TOPICAL 2 % 15 g
|
FUSIDATE SODIUM
|
D06AX01
|
DERMATOLOGICALS
|
ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
|
ANTIBIOTICS FOR TOPICAL USE
|
Other antibiotics for topical use
|
fusidic acid
|
BDR Pharmaceuticals
|
BDREM INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg mg
|
REMDESIVIR INJECTION, POWDER, FOR SOLUTION PARENTERAL 100 mg
|
REMDESIVIR
|
J05
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
| null | null | null |
Shahre Daru
|
CLOMIPRAMINE TABLET ORAL 50 mg
|
CLOMIPRAMINE HYDROCHLORIDE TABLET ORAL 50 mg
|
CLOMIPRAMINE HYDROCHLORIDE
|
N06AA04
|
NERVOUS SYSTEM
|
PSYCHOANALEPTICS
|
ANTIDEPRESSANTS
|
Non-selective monoamine reuptake inhibitors
|
clomipramine
|
Toliddaru Pharma. Co.
|
PRANOL TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE
|
C07AA05
|
CARDIOVASCULAR SYSTEM
|
BETA BLOCKING AGENTS
|
BETA BLOCKING AGENTS
|
Beta blocking agents, non-selective
|
propranolol
|
Caspian Tamin Co.
|
PYROMOL INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 g
|
ACETAMINOPHEN INJECTION, SOLUTION, CONCENTRATE INTRAVENOUS 150 mg/1mL 6.7 mL
|
ACETAMINOPHEN
|
N02BE01
|
NERVOUS SYSTEM
|
ANALGESICS
|
OTHER ANALGESICS AND ANTIPYRETICS
|
Anilides
|
paracetamol
|
Jalinous Pharmaceutical Co.
|
ESNEXOM TABLET, DELAYED RELEASE ORAL 20 mg
|
ESOMEPRAZOLE TABLET, DELAYED RELEASE ORAL 20 mg
|
ESOMEPRAZOLE
|
A02BC05
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
esomeprazole
|
Tehran Chemie Pharmaceutical Co.
|
G-MAX SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN SYRUP ORAL 100 mg/5mL 60 mL
|
GUAIFENESIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
null |
FLUCONAZOLE (ZAHRAVI) 100MG CAP CAPSULE ORAL 100 mg
|
FLUCONAZOLE CAPSULE ORAL 100 mg
|
FLUCONAZOLE
|
J02AC01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
ANTIMYCOTICS FOR SYSTEMIC USE
|
Triazole derivatives
|
fluconazole
|
Iran Hormone
|
LONGIL TABLET ORAL 1.5 mg
|
LEVONORGESTREL TABLET ORAL 1.5 mg
|
LEVONORGESTREL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Iran Najo
|
DICLOFENAC-NAJO SUPPOSITORY RECTAL 50 mg g
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Rouzdarou
|
TADARECTIL TABLET ORAL 10 mg
|
TADALAFIL TABLET ORAL 10 mg
|
TADALAFIL
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Exir Pharmaceutical Company
|
THEOPHYLLINE-G SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN
|
R03DA54
|
RESPIRATORY SYSTEM
|
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
|
Xanthines
|
theophylline, combinations excl. psycholeptics
|
Sobhandarou
|
CLIDINIUM-C TABLET ORAL 2.5 mg/5 mg
|
CLIDINIUM / CHLORDIAZEPOXIDE TABLET ORAL 2.5 mg/5 mg
|
CLIDINIUM / CHLORDIAZEPOXIDE
|
A03CA02
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS
|
Synthetic anticholinergic agents in combination with psycholeptics
|
clidinium and psycholeptics
|
Aburaihan Pharmaceutical Co
|
FERTIGEST INJECTION PARENTERAL 50 mg/1mL 1 mL
|
PROGESTERONE INJECTION PARENTERAL 50 mg/1mL 1 mL
|
PROGESTERONE
|
G03DA04
|
GENITO URINARY SYSTEM AND SEX HORMONES
|
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
|
PROGESTOGENS
|
Pregnen (4) derivatives
|
progesterone
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
THEOZIN SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN SOLUTION ORAL 50 mg/30 mg/5mL 120 mL
|
THEOPHYLLINE / GUAIFENESIN
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Toliddaru Pharma. Co.
|
PRANOL TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE TABLET ORAL 10 mg
|
PROPRANOLOL HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sobhandarou
|
SOPEXOL TABLET ORAL 0.25 mg
|
PRAMIPEXOLE DIHYDROCHLORIDE TABLET ORAL 0.25 mg
|
PRAMIPEXOLE DIHYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Amin Pharmaceutical Co.
|
DICYCLOMINE TABLET ORAL 10 mg
|
DICYCLOMINE HYDROCHLORIDE TABLET ORAL 10 mg
|
DICYCLOMINE HYDROCHLORIDE
|
A03AA07
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
|
Synthetic anticholinergics, esters with tertiary amino group
|
dicycloverine
|
Hakim Pharmaceutical Co.
|
BIPERIDEN-HAKIM TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE TABLET ORAL 2 mg
|
BIPERIDEN HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Dr. Abidi Pharmaceuticals
|
COLDAX DAY & NIGHT TABLET ORAL 15 mg/2 mg/5 mg/500 mg
|
ADULT COLD PREPARATIONS (7-23) TABLET ORAL 15 mg/2 mg/5 mg/500 mg
|
ADULT COLD PREPARATIONS (7-23)
|
R05X
|
RESPIRATORY SYSTEM
|
COUGH AND COLD PREPARATIONS
|
OTHER COLD PREPARATIONS
| null | null |
Alhavi
|
ZADIKID SYRUP ORAL 1 mg/5mL 120 mL
|
KETOTIFEN SYRUP ORAL 1 mg/5mL 120 mL
|
KETOTIFEN
|
R06AX17
|
RESPIRATORY SYSTEM
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
ANTIHISTAMINES FOR SYSTEMIC USE
|
Other antihistamines for systemic use
|
ketotifen
|
Emad Darman Pars
|
ELOCOMAD CREAM TOPICAL 0.1 % 30 g
|
MOMETASONE FUROATE CREAM TOPICAL 0.1 % 30 g
|
MOMETASONE FUROATE
|
D07AC13
|
DERMATOLOGICALS
|
CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
|
CORTICOSTEROIDS, PLAIN
|
Corticosteroids, potent (group III)
|
mometasone
|
NO.115 , Jalal St ., Esteqlal Town ,Tehran
|
THIORIDAZINE TABLET ORAL 100 mg
|
THIORIDAZINE HYDROCHLORIDE TABLET ORAL 100 mg
|
THIORIDAZINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Sepidaj Pharmaceutical Company
|
MINOXIDIL-SEPIDAJ SOLUTION TOPICAL 50 mg/1mL 60 mL
|
MINOXIDIL SOLUTION TOPICAL 50 mg/1mL 60 mL
|
MINOXIDIL
|
D11AX01
|
DERMATOLOGICALS
|
OTHER DERMATOLOGICAL PREPARATIONS
|
OTHER DERMATOLOGICAL PREPARATIONS
|
Other dermatologicals
|
minoxidil
|
Minoo Pharmaceutical Cosmetic & Hygienic Co.
|
CLOZAPINE MINOO TABLET ORAL 25 mg
|
CLOZAPINE TABLET ORAL 25 mg
|
CLOZAPINE
|
N05AH02
|
NERVOUS SYSTEM
|
PSYCHOLEPTICS
|
ANTIPSYCHOTICS
|
Diazepines, oxazepines, thiazepines and oxepines
|
clozapine
|
Tehran Chemie Pharmaceutical Co.
|
DEMITRON TABLET ORAL 4 mg
|
ONDANSETRON TABLET ORAL 4 mg
|
ONDANSETRON
|
A04AA01
|
ALIMENTARY TRACT AND METABOLISM
|
ANTIEMETICS AND ANTINAUSEANTS
|
ANTIEMETICS AND ANTINAUSEANTS
|
Serotonin (5HT3) antagonists
|
ondansetron
|
Cinnagen Co.
|
CINNAPOIETIN INJECTION PARENTERAL 4000 [iU]/0.3mL [iU]
|
EPOETIN INJECTION PARENTERAL 4000 [iU]/0.3mL
|
EPOETIN
|
B03XA01
|
BLOOD AND BLOOD FORMING ORGANS
|
ANTIANEMIC PREPARATIONS
|
OTHER ANTIANEMIC PREPARATIONS
|
Other antianemic preparations
|
erythropoietin
|
Rouzdarou
|
MEFENAMIC ACID CAPSULE ORAL 250 mg
|
MEFENAMIC ACID CAPSULE ORAL 250 mg
|
MEFENAMIC ACID
|
M01AG01
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Fenamates
|
mefenamic acid
|
Shafa Pharmaceutical & Hygienic Mfg.co.
|
ESOMEPRAZOLE-SHAFA CAPSULE, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE CAPSULE, DELAYED RELEASE ORAL 40 mg
|
ESOMEPRAZOLE
|
A02BC05
|
ALIMENTARY TRACT AND METABOLISM
|
DRUGS FOR ACID RELATED DISORDERS
|
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
|
Proton pump inhibitors
|
esomeprazole
|
Arnikahealth Pharmaceutical Co
|
DICLOFENAC SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM SUPPOSITORY RECTAL 50 mg
|
DICLOFENAC SODIUM
|
M01AB05
|
MUSCULO-SKELETAL SYSTEM
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
|
ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
|
Acetic acid derivatives and related substances
|
diclofenac
|
Afachemi
|
AFAPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g g
|
MEROPENEM INJECTION, POWDER, FOR SOLUTION PARENTERAL 1 g
|
MEROPENEM
|
J01DH02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
OTHER BETA-LACTAM ANTIBACTERIALS
|
Carbapenems
|
meropenem
|
Iran Daru
|
ACICLOVIR CREAM TOPICAL 5 % 10 g
|
ACICLOVIR CREAM TOPICAL 5 % 10 g
|
ACICLOVIR
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
L Molteni & C Dei Fratelli Alitti Societa Di Esercizio Spa
|
ROPIVACAINA MOLTENI INJECTION, SOLUTION PARENTERAL 10 mg/1mL 10 mg
|
ROPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION PARENTERAL 10 mg/1mL 10 mL
|
ROPIVACAINE HYDROCHLORIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Tehran Darou Pharmaceutical Co.
|
NALIDEX TABLET ORAL 500 mg
|
NALIDIXIC ACID TABLET ORAL 500 mg
|
NALIDIXIC ACID
|
J01MB02
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIBACTERIALS FOR SYSTEMIC USE
|
QUINOLONE ANTIBACTERIALS
|
Other quinolones
|
nalidixic acid
|
Pakdarou Pharmaceutical Company
|
LACTULOSE-PAKDAROU SYRUP ORAL 10 g/15mL 240 mL
|
LACTULOSE SYRUP ORAL 10 g/15mL 240 mL
|
LACTULOSE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Avicenna Laboratories Inc.
|
ACICLOVIR TABLET ORAL 400 mg
|
ACICLOVIR TABLET ORAL 400 mg
|
ACICLOVIR
|
J05AB01
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
aciclovir
|
Aburaihan Pharmaceutical Co
|
TRIROLE CAPSULE ORAL 200 mg
|
FENOFIBRATE CAPSULE ORAL 200 mg
|
FENOFIBRATE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Fanavarihaye Novin Darouie Atieh
|
NORSTOR TABLET ORAL 200 mg/50 mg
|
LEVODOPA / BENSERAZIDE TABLET ORAL 200 mg/50 mg
|
LEVODOPA / BENSERAZIDE
|
N04BA02
|
NERVOUS SYSTEM
|
ANTI-PARKINSON DRUGS
|
DOPAMINERGIC AGENTS
|
Dopa and dopa derivatives
|
levodopa and decarboxylase inhibitor
|
Darou Pakhsh
|
VITAMIN B1 TABLET ORAL 100 mg
|
VITAMIN B1 (THIAMINE) TABLET ORAL 100 mg
|
VITAMIN B1 (THIAMINE)
|
A11DA01
|
ALIMENTARY TRACT AND METABOLISM
|
VITAMINS
|
VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12
|
Vitamin B1, plain
|
thiamine (vit B1)
|
Darou Pakhsh
|
HYDROCHLOROTHIAZIDE TABLET ORAL 50 mg
|
HYDROCHLOROTHIAZIDE TABLET ORAL 50 mg
|
HYDROCHLOROTHIAZIDE
|
J05AB14
|
ANTIINFECTIVES FOR SYSTEMIC USE
|
ANTIVIRALS FOR SYSTEMIC USE
|
DIRECT ACTING ANTIVIRALS
|
Nucleosides and nucleotides excl. reverse transcriptase inhibitors
|
valganciclovir
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.